Introduction
Diabetic retinopathy remains a primary cause of vision loss worldwide. Early intervention through regular screenings is effective but hampered by the massive volume of retinal fundus images that require expert manual review. Automating this process is challenging due to non-uniform illumination and the morphological variability of lesions (exudates). This paper presents a robust automated pipeline, the "Enhanced Minimum Distance Discriminant (MDD)," designed to filter healthy images and identify abnormalities with high sensitivity.
Methodology
The proposed Enhanced MDD pipeline consists of three critical stages to ensure reliable detection across varying image qualities.
1. Non-linear Brightness Adjustment
To mitigate uneven lighting—a common issue where the periphery of the retina appears darker than the center—the system applies a non-linear transformation: $y = \beta \cdot x^\alpha$. This adjustment selectively enhances darker regions without over-saturating well-lit areas, ensuring that peripheral lesions are not overlooked.
2. Statistical Classification (MDD)
The system converts images from the standard RGB color space into a spherical coordinate system $(L, \theta, \phi)$. Here, $L$ represents intensity, while $\theta$ and $\phi$ capture chromaticity. By employing a Bayesian-derived Minimum Distance Discriminant, the classifier compares pixel color vectors against established clusters for lesions and background tissues. This separation of intensity from color allows for more consistent detection across different lighting conditions.
3. Local-Window Verification
Brightness enhancement can occasionally amplify background noise, leading to false positives. To counter this, a verification step uses an $M \times M$ local window to calculate a contrast measure ($D$). Since true lesions typically possess sharper edges than the gradual gradients of the retinal background, this step filters out artifacts that lack the distinct boundaries of real exudates.
Results and Performance
The Enhanced MDD system was evaluated on a dataset of 154 color retinal images (54 abnormal, 100 normal) sourced from clinics in Singapore.
The results demonstrated a significant improvement over baseline methods. While a standard MDD classifier missed approximately 33% of abnormal images, the Enhanced MDD achieved 100% sensitivity, identifying every image containing lesions. Furthermore, the system correctly classified 70% of normal images as healthy. In a clinical screening workflow, this translates to a 70% reduction in manual workload, as specialists only need to review the remaining 30% of "suspicious" healthy images and the confirmed abnormal cases.
Discussion and Future Work
A significant technical hurdle in retinal image analysis is the presence of the optic disc. This anatomical feature shares color characteristics with lesions, often leading to misclassification.
While the current pipeline effectively isolates lesions, integrating specialized optic disc masking algorithms is a priority for future development. Additionally, expanding the dataset to include diverse ethnicities and camera types will be necessary to validate the system's generalizability. Future iterations may also move beyond binary classification to provide automated grading of retinopathy severity.
Conclusion
The Enhanced MDD pipeline offers a scalable solution for diabetic retinopathy screening. By combining intelligent brightness normalization with statistical color classification and local edge verification, the system achieves the 100% sensitivity required for medical applications while significantly reducing the burden on healthcare professionals.
Summary updated